U.S. Markets closed

Geron to Present at the Piper Jaffray Healthcare Conference

MENLO PARK, Calif., November 26, 2013 - Geron Corporation (GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 12:30 p.m. Eastern Time on Wednesday, December 4, at the 25th Annual Piper Jaffray Healthcare Conference in New York.

A live webcast of the presentation will be available at http://www.media-server.com/m/p/fz42u5na. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company developing a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.


Anna Krassowska, Ph.D.
Investor and Media Relations


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Geron Corp. via GlobeNewswire